author-photo

Denise Bury

11

Papers

61

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Post Hoc Health-Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials

2021 Health and Quality of Life Outcomes
Show All
- Source
- Cite
- Save
Citations (0)
Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial

2020
Show All
- Source
- Cite
- Save
Citations (0)
Significant and Clinically Meaningful Health-Related Quality of Life Improvements With Alemtuzumab in RRMS Patients in Clinical Practice: Interim Results From a Prospective, Non-Interventional, Real-World Study (PROMiS) (P3.2-098)

2019 Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Aflibercept plus FOLFIRI for Second-Line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

2019 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Isatuximab Plus Pomalidomide and Dexamethasone: Icaria-MM Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (4)
An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

2019 BJUI
Show All
- Source
- Cite
- Save
Citations (12)